NCT02840500View on ClinicalTrials.gov

Quality of Life Study in Patients With Cancer Breakthrough Pain Treated in Palliative Care Units

CompletedOBSERVATIONAL
Enrollment

101

Participants

Timeline

Start Date

June 27, 2016

Primary Completion Date

December 31, 2017

Study Completion Date

March 31, 2018

Conditions
Breakthrough Pain
Interventions
OTHER

No intervention

No intervention

Trial Locations (10)

18014

Hospital Virgen de las Nieves, Granada

25198

Hospital Arnau de Vilanova, Lleida

28007

Hospital Gregorio Marañón, Madrid

28040

Fundación Jiménez Díaz, Madrid

32005

Complejo Hospitalario de Ourense, Ourense

41013

Hospital Virgen del Rocío, Seville

45005

Hospital Virgen de la Salud, Toledo

08100

Hospital de Mollet, Mollet del Vallès

07007

Hospital Sant Joan de Deu, Palma

08036

Hospital Clínic, Barcelona

Sponsors
All Listed Sponsors
lead

Angelini Farmacéutica

INDUSTRY

NCT02840500 - Quality of Life Study in Patients With Cancer Breakthrough Pain Treated in Palliative Care Units | Biotech Hunter | Biotech Hunter